Literature DB >> 30654635

Role of circular RNAs in cardiovascular diseases.

Xue Gong1, Gengze Wu1, Chunyu Zeng1.   

Abstract

IMPACT STATEMENT: Circular RNAs are important regulators of multiple biological processes such as organogenesis and oncogenesis. Although the bulk of concerning studies focused on revealing their diversified roles in various types of cancers, reports began to accumulate in cardiovascular field these days. We summarize circular RNAs implicated in cardiovascular diseases, aiming to highlight the advances in the knowledge of such diseases and their potential of being promising target for diagnosis and therapy.

Entities:  

Keywords:  Circular RNA; biomarkers; cardiology; pathology; therapy; vascular

Mesh：

Substances：

Year:  2019        PMID： 30654635      PMCID： PMC6405821          DOI： 10.1177/1535370218822988

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


  84 in total

Review 1.  The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

Authors:  J G Seidman; C Seidman
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications.

Authors:  Xiaobin Luo; Haijun Zhang; Jiening Xiao; Zhiguo Wang
Journal:  Cell Physiol Biochem       Date:  2010-05-18

Review 3.  Modulation of smooth muscle cell proliferation and migration: role of smooth muscle cell heterogeneity.

Authors:  M L Bochaton-Piallat; G Gabbiani
Journal:  Handb Exp Pharmacol       Date:  2005

Review 4.  The search for new cardiovascular biomarkers.

Authors:  Robert E Gerszten; Thomas J Wang
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

5.  Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

Authors:  S Talwar; I B Squire; P F Downie; A M Mccullough; M C Campton; J E Davies; D B Barnett; L L Ng
Journal:  Eur Heart J       Date:  2000-09       Impact factor: 29.983

6.  Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.

Authors:  Olga Jarinova; Alexandre F R Stewart; Robert Roberts; George Wells; Paulina Lau; Thet Naing; Christine Buerki; Bradley W McLean; Richard C Cook; Joel S Parker; Ruth McPherson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

7.  Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.

Authors:  Christin E Burd; William R Jeck; Yan Liu; Hanna K Sanoff; Zefeng Wang; Norman E Sharpless
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

8.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

Review 9.  Molecular mechanisms of inherited cardiomyopathies.

Authors:  Diane Fatkin; Robert M Graham
Journal:  Physiol Rev       Date:  2002-10       Impact factor: 37.312

10.  Genomewide association analysis of coronary artery disease.

Authors:  Nilesh J Samani; Jeanette Erdmann; Alistair S Hall; Christian Hengstenberg; Massimo Mangino; Bjoern Mayer; Richard J Dixon; Thomas Meitinger; Peter Braund; H-Erich Wichmann; Jennifer H Barrett; Inke R König; Suzanne E Stevens; Silke Szymczak; David-Alexandre Tregouet; Mark M Iles; Friedrich Pahlke; Helen Pollard; Wolfgang Lieb; Francois Cambien; Marcus Fischer; Willem Ouwehand; Stefan Blankenberg; Anthony J Balmforth; Andrea Baessler; Stephen G Ball; Tim M Strom; Ingrid Braenne; Christian Gieger; Panos Deloukas; Martin D Tobin; Andreas Ziegler; John R Thompson; Heribert Schunkert
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245
View more
  4 in total

Review 1.  MicroRNAs and Circular RNAs in Lipoprotein Metabolism.

Authors:  Pablo Fernández-Tussy; Inmaculada Ruz-Maldonado; Carlos Fernández-Hernando
Journal:  Curr Atheroscler Rep       Date:  2021-05-10       Impact factor: 5.967

Review 2.  Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.

Authors:  Amit K Rai; Brooke Lee; Ramesh Gomez; Deepu Rajendran; Mahmood Khan; Venkata Naga Srikanth Garikipati
Journal:  Front Physiol       Date:  2021-01-22       Impact factor: 4.566

3.  circ_0023461 Silencing Protects Cardiomyocytes from Hypoxia-Induced Dysfunction through Targeting miR-370-3p/PDE4D Signaling.

Authors:  Kai Ren; Buying Li; Liqing Jiang; Zhiheng Liu; Fan Wu; Yi Zhang; Jincheng Liu; Weixun Duan
Journal:  Oxid Med Cell Longev       Date:  2021-10-01       Impact factor: 6.543

4.  Circ_0124644 Serves as a ceRNA for miR-590-3p to Promote Hypoxia-Induced Cardiomyocytes Injury via Regulating SOX4.

Authors:  Juan Tan; Weinan Pan; Huilin Chen; Yafang Du; Peiyong Jiang; Dianmei Zeng; Jie Wu; Kuang Peng
Journal:  Front Genet       Date:  2021-06-25       Impact factor: 4.599
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.